Combined effects of clonal hematopoiesis of intermediate potential and P2Y12 inhibitors on outcomes of patients with ST-segment elevation myocardial infarction: A prospective study
Event:
ESC Congress 2025
Topic:
Pharmacotherapy
Session:
New therapeutic insights into coronary artery disease